Here we showed that membrane PL composition, controlled by LPCAT3, modulates insulin action on both glucose and lipid metabolism in the liver, and that upregulation of Lpcat3 expression by hyperinsulinemia and the increase in PL unsaturation are involved in the pathogenesis of insulin resistance, especially hepatic selective insulin resistance. The gene discussed is LPCAT3; the disease is Hyperinsulinemia.